Pomerantz Law Firm Issues Reminder Regarding Class Action Lawsuit Against Hims & Hers Health, Inc.

Investor Alert: Class Action Lawsuit Against Hims & Hers Health

Pomerantz LLP, a New York-based law firm known for its expertise in corporate and securities litigation, has officially launched a class action lawsuit against Hims & Hers Health, Inc. This alert serves as a timely reminder for investors who may have suffered losses due to their association with Hims & Hers, especially amid allegations of securities fraud and unethical business practices.

The class action revolves around whether Hims & Hers and its leadership engaged in deceptive practices that led to significant investor losses. Those impacted are advised to reach out to Danielle Peyton at Pomerantz, either via phone or email, to discuss their situation and potentially join the class. The deadline to opt to be a Lead Plaintiff is set for August 25, 2025. For those interested, details about the case and the full complaint are available on the firm's official website.

Key issues raised in the lawsuit are linked to Hims & Hers’ recent partnership with pharmaceutical giant Novo Nordisk. Initially celebrated, this collaboration faced serious fallout when Novo Nordisk publicly announced its termination of the deal. The company cited breaches related to patient safety due to Hims & Hers' suspected promotional misconduct of certain products, including illegitimate versions of their medication, Wegovy®. Novo Nordisk's statement highlights concerns about the origins and safety of ingredients in these products, which allegedly involved foreign and unauthorized suppliers, specifically from China.

The fallout from this announcement was swift and severe, as Hims & Hers experienced a staggering 34.63% decline in stock value, reflecting loss of investor confidence and the gravity of the allegations. Shares plummeted from approximately $64.22 to $41.98 following the news, presenting a significant risk to those who invested during the contested period.

Pomerantz LLP has a long-standing history of fighting for the rights of investors wronged by corporate misconduct. Founded by the late Abraham L. Pomerantz, the firm has a reputation for holding companies accountable to their shareholders and has successfully recovered numerous multi-million dollar settlements for class members affected by securities fraud.

For investors of Hims & Hers, not only is it crucial to stay informed about the ongoing legal proceedings but also to take timely action in participating in the lawsuit. The firm encourages any holder of Hims & Hers' shares, purchased during the alleged Class Period, to consider their legal rights and potential compensation entitled under the law.

As the situation develops, further updates regarding the lawsuit and any new evidence presented will likely be pivotal in shaping the outcomes for affected investors. Monitoring communications from Pomerantz LLP and official statements from Hims & Hers will be essential for those looking to navigate this tumultuous phase effectively.

In conclusion, if you are an investor in Hims & Hers Health, this is an urgent situation that requires diligence and attention to ensure your rights are protected in the face of serious allegations. The firm remains poised to advocate fiercely on behalf of investors, underscoring the necessity of collective action in the fight against securities fraud.